ST. LOUIS, Mo. — Leinco Technologies, a specialty manufacturer of life science reagents used in drug discovery research and in vitro diagnostics applications, today announced a majority recapitalization of the company by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to […]
CHELMSFORD, Mass. — Brooks Automation, Inc. (Nasdaq: BRKS) announced at its investor day earlier today that it is changing its name to Azenta, Inc. and will begin trading on Nasdaq under the ticker symbol AZTA, effective at the open of market trading on December 1, 2021. This change follows the previously announced launch of the life sciences brand, Azenta Life Sciences. Following […]
Existing ZAGENO investors also participated in the financing CAMBRIDGE, Mass. and BERLIN — ZAGENO, a leading enterprise marketplace solution connecting eCommerce to life science, today announced that it completed a $60 million financing round led by General Catalyst and a large, vertically integrated, nonprofit healthcare organization. The new funding, which includes ongoing investments from Grazia […]
Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights LONDON & BOSTON — Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 […]
Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financing from Telegraph Hill Partners (“THP”), a life science venture capital and growth equity firm based in San Francisco, CA. The Company’s lead […]
Designed to bypass the oligo bottleneck in genomic research and development, the new platform will build on the success of DNA Script’s recently launched SYNTAX System using their innovative Enzymatic DNA Synthesis technology SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a leader in benchtop enzymatic DNA synthesis, today announced that the company has […]
NEW YORK — Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, […]
Qlucore AB (public) (“Qlucore” or “Company”) has today received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares will be 5th November 2021. Trading will be done with the ticker QCORE. “This paves the way for a new phase in […]
FORT LAUDERDALE, Fla. — Gemini Bioproducts, LLC (“GeminiBio”), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids, announced today that it has secured financing from BroadOak Capital Partners, LLC (“BroadOak”), a boutique direct investment and advisory firm focused on life science research tools and diagnostics. The transaction with BroadOak provides GeminiBio additional […]
Funds to drive commercial expansion as growing number of facilities bring genomics into communities worldwide ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
